Pfizer

Page 37 of 37

Earns Pfizer
Features

In speed mode, FDA approves Pfizer’s big new drug early

By
February 4, 2015
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Zoetis shares spike on reported Ackman stake purchase

By
November 11, 2014
Fortune
Features

Facebook earnings and MSG split — 5 things to know today

By
October 28, 2014
New Targets and new houses (oh, and Ebola) — 5 things to know today
Features

New Targets and new houses (oh, and Ebola) — 5 things to know today

By
October 24, 2014
Fortune
Finance

Are U.S. corporate tax inversions a necessary crisis?

By
July 18, 2014
Canada: A penalty box for pharma innovation
International

Canada: A penalty box for pharma innovation

By
July 2, 2014
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance

AstraZeneca fails to win FDA panel backing for cancer treatment

By
June 26, 2014
AstraZeneca shareholders upset by “quick” Pfizer rejection
Finance

AstraZeneca shareholders upset by “quick” Pfizer rejection

By
May 20, 2014
Fortune
Finance

AstraZeneca rejects higher ‘final’ offer from Pfizer

By
May 19, 2014
Does the AstraZeneca-Pfizer deal make scientific sense?
Features

Does the AstraZeneca-Pfizer deal make scientific sense?

By
May 15, 2014
Pfizer admits to potential job losses in AstraZeneca takeover

Pfizer admits to potential job losses in AstraZeneca takeover

By
May 13, 2014
Fortune
Finance

Pfizer prepares to woo U.K. lawmakers in bid for rival AstraZeneca

By
May 12, 2014
AstraZeneca shares climb in hopes of bigger Pfizer offer

AstraZeneca shares climb in hopes of bigger Pfizer offer

By
May 9, 2014
Pfizer’s massive tax play for AstraZeneca
Finance

Pfizer’s massive tax play for AstraZeneca

By
April 29, 2014
Behind Pfizer’s latest upheaval at the top
Management

Behind Pfizer’s latest upheaval at the top

By
December 17, 2013

Most Popular